• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于卵巢过度刺激综合征病因病理的数据系统评价。

Systematic review of data concerning etiopathology of ovarian hyperstimulation syndrome.

作者信息

Delvigne Annick, Rozenberg Serge

机构信息

IVF Centre, Department of Obstetrics-Gynaecology, University Hospital St Pierre (Free University of Brussels-ULB), Brussels, Belgium.

出版信息

Int J Fertil Womens Med. 2002 Sep-Oct;47(5):211-26.

PMID:12469708
Abstract

The ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication of ovarian stimulation occurring during the luteal phase or early pregnancy. It has been observed over the last 60 years, since gonadotropins were first used to induce ovulation. The prevalence varies, according to study, from 0.5% to 5%. The pathogenesis of OHSS is, apparently, complex. It involves a vasoactive mediator, secreted by the ovaries (in overabundance) after artificial stimulation. Estradiol, which is a marker of ovarian response, is not the mediator. The candidate mediators reviewed are prolactin and prostaglandins; the ovarian prorenin-renin-angiotensin system; cytokines (including allergy-cytokines-histamine as a system); VEGF; angiogenin; the Kinin-Kallikrein system; VCAM and ICAM; selectins; von Willebrand factor; and endothelin. The main conclusion is that OHSS is the result of disturbance of the basically inflammation-like normal ovulation process, and has as its main feature capillary leakage and transmission of mediators to other compartments.

摘要

卵巢过度刺激综合征(OHSS)是在黄体期或妊娠早期发生的卵巢刺激的医源性并发症。自首次使用促性腺激素诱导排卵以来,在过去60年中一直观察到这种情况。根据研究,其患病率从0.5%到5%不等。OHSS的发病机制显然很复杂。它涉及人工刺激后卵巢(过量)分泌的一种血管活性介质。雌二醇是卵巢反应的标志物,但不是介质。审查的候选介质有催乳素和前列腺素;卵巢前肾素-肾素-血管紧张素系统;细胞因子(包括作为一个系统的过敏细胞因子-组胺);血管内皮生长因子(VEGF);血管生成素;激肽-激肽释放酶系统;血管细胞黏附分子(VCAM)和细胞间黏附分子(ICAM);选择素;血管性血友病因子;以及内皮素。主要结论是,OHSS是基本类似炎症的正常排卵过程紊乱的结果,其主要特征是毛细血管渗漏和介质向其他腔隙的传递。

相似文献

1
Systematic review of data concerning etiopathology of ovarian hyperstimulation syndrome.关于卵巢过度刺激综合征病因病理的数据系统评价。
Int J Fertil Womens Med. 2002 Sep-Oct;47(5):211-26.
2
"Coasting" (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.“ coasting”(停用促性腺激素)预防卵巢过度刺激综合征 。
Cochrane Database Syst Rev. 2002(3):CD002811. doi: 10.1002/14651858.CD002811.
3
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).针对接受体外受精加卵胞浆内单精子注射(IVF/ICSI)的女性,使用卵巢储备标志物进行个性化促性腺激素剂量选择。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2.
4
Update on ovarian hyperstimulation syndrome: Part 1--Incidence and pathogenesis.卵巢过度刺激综合征最新进展:第1部分——发病率与发病机制
Int J Fertil Womens Med. 2007 Jan-Feb;52(1):11-26.
5
The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome.激肽释放酶-激肽系统而非血管内皮生长因子,在与卵巢过度刺激综合征相关的血管通透性增加中起作用。
J Mol Endocrinol. 1998 Jun;20(3):363-74. doi: 10.1677/jme.0.0200363.
6
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.芳香化酶抑制剂(来曲唑)用于多囊卵巢综合征的不孕女性。
Cochrane Database Syst Rev. 2018 May 24;5(5):CD010287. doi: 10.1002/14651858.CD010287.pub3.
7
Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome.静脉输注白蛋白预防重度卵巢过度刺激综合征
Cochrane Database Syst Rev. 2002(2):CD001302. doi: 10.1002/14651858.CD001302.
8
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
9
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.芳香化酶抑制剂(来曲唑)在多囊卵巢综合征不孕妇女中的促排卵作用。
Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD010287. doi: 10.1002/14651858.CD010287.pub4.
10
Embryo freezing for preventing Ovarian Hyperstimulation Syndrome.胚胎冷冻以预防卵巢过度刺激综合征。
Cochrane Database Syst Rev. 2002(2):CD002806. doi: 10.1002/14651858.CD002806.

引用本文的文献

1
Ovarian Hyperstimulation Syndrome (OHSS): A Narrative Review and Legal Implications.卵巢过度刺激综合征(OHSS):一篇叙述性综述及法律影响
J Pers Med. 2024 Aug 28;14(9):915. doi: 10.3390/jpm14090915.
2
A Case with Severe Endometriosis, Ovarian Hyperstimulation Syndrome, and Isolated Unilateral Pleural Effusion after IVF.一例体外受精后发生严重子宫内膜异位症、卵巢过度刺激综合征及孤立性单侧胸腔积液的病例。
Case Rep Obstet Gynecol. 2017;2017:8243204. doi: 10.1155/2017/8243204. Epub 2017 Jul 10.
3
Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation.
用于体外成熟生育治疗的人绒毛膜促性腺激素预处理
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD008720. doi: 10.1002/14651858.CD008720.pub2.
4
Regulation of Endothelial Permeability in the Corpus Luteum: A Review of the Literature.黄体中内皮通透性的调节:文献综述
Geburtshilfe Frauenheilkd. 2013 Nov;73(11):1107-1111. doi: 10.1055/s-0033-1351032.
5
The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome.卵巢过度刺激综合征的病理生理学:一种未被认识的综合征。
Fertil Steril. 2010 Sep;94(4):1392-1398. doi: 10.1016/j.fertnstert.2009.07.1662.
6
Ovarian hyperstimulation syndrome and prophylactic human embryo cryopreservation: analysis of reproductive outcome following thawed embryo transfer.卵巢过度刺激综合征与预防性人类胚胎冷冻保存:冻融胚胎移植后生殖结局分析。
J Ovarian Res. 2008 Nov 6;1(1):7. doi: 10.1186/1757-2215-1-7.
7
No association between the microsatellite polymorphism (TTTTA)n in the promoter of the CYP11A gene and ovarian hyperstimulation syndrome.CYP11A基因启动子区微卫星多态性(TTTTA)n与卵巢过度刺激综合征之间无关联。
J Assist Reprod Genet. 2006 Jan;23(1):29-32. doi: 10.1007/s10815-005-9009-x. Epub 2006 Jan 4.